Calle Elizabeth A, Hill Ryan C, Leiby Katherine L, Le Andrew V, Gard Ashley L, Madri Joseph A, Hansen Kirk C, Niklason Laura E
Department of Biomedical Engineering, Yale University, New Haven, CT 06519, USA; Yale School of Medicine, Yale University, New Haven, CT 06519, USA.
Department of Biochemistry and Molecular Genetics, University of Colorado, Denver, Aurora, CO 80045, USA.
Acta Biomater. 2016 Dec;46:91-100. doi: 10.1016/j.actbio.2016.09.043. Epub 2016 Sep 29.
Extracellular matrix is a key component of many products in regenerative medicine. Multiple regenerative medicine products currently in the clinic are comprised of human or xenogeneic extracellular matrix. In addition, whole-organ regeneration exploits decellularized native organs as scaffolds for organotypic cell culture. However, precise understanding of the constituents of such extracellular matrix-based implants and scaffolds has sorely lagged behind their use. We present here an advanced protein extraction method using known quantities of proteotypic C-labeled peptides to quantify matrix proteins in native and decellularized lung tissues. Using quantitative proteomics that produce picomole-level measurements of a large number of matrix proteins, we show that a mild decellularization technique ("Triton/SDC") results in near-native retention of laminins, proteoglycans, and other basement membrane and ECM-associated proteins. Retention of these biologically important glycoproteins and proteoglycans is quantified to be up to 27-fold higher in gently-decellularized lung scaffolds compared to scaffolds generated using a previously published decellularization regimen. Cells seeded onto this new decellularized matrix also proliferate robustly, showing positive staining for proliferating cell nuclear antigen (PCNA). The high fidelity of the gently decellularized scaffold as compared to the original lung extracellular matrix represents an important step forward in the ultimate recapitulation of whole organs using tissue-engineering techniques. This method of ECM and scaffold protein analysis allows for better understanding, and ultimately quality control, of matrices that are used for tissue engineering and human implantation. These results should advance regenerative medicine in general, and whole organ regeneration in particular.
The extracellular matrix (ECM) in large part defines the biochemical and mechanical properties of tissues and organs; these inherent cues make acellular ECM scaffolds potent substrates for tissue regeneration. As such, they are increasingly prevalent in the clinic and the laboratory. However, the exact composition of these scaffolds has been difficult to ascertain. This paper uses targeted proteomics to definitively quantify 71 proteins present in acellular lung ECM scaffolds. We use this technique to compare two decellularization methods and demonstrate superior retention of ECM proteins important for cell adhesion, migration, proliferation, and differentiation in scaffolds treated with low-concentration detergent solutions. In the long term, the ability to acquire quantitative biochemical data about biological substrates will facilitate the rational design of engineered tissues and organs based on precise cell-matrix interactions.
细胞外基质是再生医学中许多产品的关键组成部分。目前临床上的多种再生医学产品都由人源或异种细胞外基质组成。此外,全器官再生利用脱细胞的天然器官作为器官型细胞培养的支架。然而,对于此类基于细胞外基质的植入物和支架成分的精确了解,远远落后于它们的应用。我们在此展示一种先进的蛋白质提取方法,该方法使用已知量的蛋白型C标记肽来定量天然和脱细胞肺组织中的基质蛋白。通过定量蛋白质组学对大量基质蛋白进行皮摩尔级别的测量,我们发现一种温和的脱细胞技术(“Triton/SDC”)能使层粘连蛋白、蛋白聚糖以及其他基底膜和细胞外基质相关蛋白近乎天然地保留下来。与使用先前公布的脱细胞方案生成的支架相比,在温和脱细胞的肺支架中,这些具有生物学重要性的糖蛋白和蛋白聚糖的保留量被量化为高出多达27倍。接种到这种新的脱细胞基质上的细胞也能强劲增殖,对增殖细胞核抗原(PCNA)呈阳性染色。与原始肺细胞外基质相比,温和脱细胞支架的高保真度代表了利用组织工程技术最终重现全器官方面向前迈出的重要一步。这种细胞外基质和支架蛋白分析方法有助于更好地理解并最终实现用于组织工程和人体植入的基质的质量控制。这些结果总体上应能推动再生医学发展,尤其在全器官再生方面。
细胞外基质(ECM)在很大程度上决定了组织和器官的生化及力学特性;这些内在线索使无细胞ECM支架成为组织再生的有力底物。因此,它们在临床和实验室中越来越普遍。然而,这些支架的确切组成一直难以确定。本文使用靶向蛋白质组学明确量化了无细胞肺ECM支架中存在的71种蛋白质。我们使用该技术比较了两种脱细胞方法,并证明在使用低浓度去污剂溶液处理的支架中,对细胞黏附、迁移、增殖和分化重要的ECM蛋白保留情况更佳。从长远来看,获取有关生物底物的定量生化数据的能力将有助于基于精确的细胞 - 基质相互作用合理设计工程化组织和器官。